644.695 USD
-25.76 (-3.84%)
Last: Feb 2, 2026, 10:41 AM
Overall IDXX gets a fundamental rating of 7 out of 10. We evaluated IDXX against 186 industry peers in the Health Care Equipment & Supplies industry. IDXX gets an excellent profitability rating and is at the same time showing great financial health properties. IDXX is not valued too expensively and it also shows a decent growth rate. This makes IDXX very considerable for quality investing!
1. Profitability
1.1 Basic Checks
- In the past year IDXX was profitable.
- IDXX had a positive operating cash flow in the past year.
- IDXX had positive earnings in each of the past 5 years.
- Each year in the past 5 years IDXX had a positive operating cash flow.
1.2 Ratios
- IDXX's Return On Assets of 30.34% is amongst the best of the industry. IDXX outperforms 100.00% of its industry peers.
- With an excellent Return On Equity value of 65.81%, IDXX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
- IDXX's Return On Invested Capital of 40.25% is amongst the best of the industry. IDXX outperforms 100.00% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for IDXX is significantly above the industry average of 8.81%.
- The 3 year average ROIC (35.08%) for IDXX is below the current ROIC(40.25%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 30.34% | ||
| ROE | 65.81% | ||
| ROIC | 40.25% |
ROA(3y)25.87%
ROA(5y)26.7%
ROE(3y)74.71%
ROE(5y)84.83%
ROIC(3y)35.08%
ROIC(5y)36.07%
1.3 Margins
- With an excellent Profit Margin value of 24.65%, IDXX belongs to the best of the industry, outperforming 95.70% of the companies in the same industry.
- IDXX's Profit Margin has improved in the last couple of years.
- IDXX has a Operating Margin of 31.34%. This is amongst the best in the industry. IDXX outperforms 98.92% of its industry peers.
- IDXX's Operating Margin has improved in the last couple of years.
- IDXX has a better Gross Margin (61.72%) than 63.98% of its industry peers.
- In the last couple of years the Gross Margin of IDXX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 31.34% | ||
| PM (TTM) | 24.65% | ||
| GM | 61.72% |
OM growth 3Y0.02%
OM growth 5Y4.78%
PM growth 3Y-0.56%
PM growth 5Y5.09%
GM growth 3Y1.27%
GM growth 5Y1.47%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IDXX is creating value.
- The number of shares outstanding for IDXX has been reduced compared to 1 year ago.
- The number of shares outstanding for IDXX has been reduced compared to 5 years ago.
- The debt/assets ratio for IDXX has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 22.72 indicates that IDXX is not in any danger for bankruptcy at the moment.
- IDXX has a Altman-Z score of 22.72. This is amongst the best in the industry. IDXX outperforms 96.24% of its industry peers.
- IDXX has a debt to FCF ratio of 1.04. This is a very positive value and a sign of high solvency as it would only need 1.04 years to pay back of all of its debts.
- IDXX's Debt to FCF ratio of 1.04 is amongst the best of the industry. IDXX outperforms 90.32% of its industry peers.
- A Debt/Equity ratio of 0.53 indicates that IDXX is somewhat dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.53, IDXX is in line with its industry, outperforming 40.86% of the companies in the same industry.
- Although IDXX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 1.04 | ||
| Altman-Z | 22.72 |
ROIC/WACC3.83
WACC10.52%
2.3 Liquidity
- IDXX has a Current Ratio of 1.18. This is a normal value and indicates that IDXX is financially healthy and should not expect problems in meeting its short term obligations.
- With a Current ratio value of 1.18, IDXX is not doing good in the industry: 81.18% of the companies in the same industry are doing better.
- A Quick Ratio of 0.87 indicates that IDXX may have some problems paying its short term obligations.
- IDXX has a worse Quick ratio (0.87) than 79.57% of its industry peers.
- The current and quick ratio evaluation for IDXX is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.18 | ||
| Quick Ratio | 0.87 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 15.16% over the past year.
- The Earnings Per Share has been growing by 18.18% on average over the past years. This is quite good.
- Looking at the last year, IDXX shows a quite strong growth in Revenue. The Revenue has grown by 8.39% in the last year.
- Measured over the past years, IDXX shows a quite strong growth in Revenue. The Revenue has been growing by 10.12% on average per year.
EPS 1Y (TTM)15.16%
EPS 3Y9.32%
EPS 5Y18.18%
EPS Q2Q%21.43%
Revenue 1Y (TTM)8.39%
Revenue growth 3Y6.62%
Revenue growth 5Y10.12%
Sales Q2Q%13.29%
3.2 Future
- IDXX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.18% yearly.
- IDXX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.43% yearly.
EPS Next Y16.89%
EPS Next 2Y14.65%
EPS Next 3Y14.13%
EPS Next 5Y14.18%
Revenue Next Year10.46%
Revenue Next 2Y9.59%
Revenue Next 3Y9.39%
Revenue Next 5Y9.43%
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- IDXX is valuated quite expensively with a Price/Earnings ratio of 51.13.
- Based on the Price/Earnings ratio, IDXX is valued a bit cheaper than 69.89% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 28.32. IDXX is valued rather expensively when compared to this.
- A Price/Forward Earnings ratio of 43.59 indicates a quite expensive valuation of IDXX.
- 68.82% of the companies in the same industry are more expensive than IDXX, based on the Price/Forward Earnings ratio.
- IDXX is valuated expensively when we compare the Price/Forward Earnings ratio to 25.57, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 51.13 | ||
| Fwd PE | 43.59 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, IDXX is valued a bit cheaper than 67.74% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of IDXX indicates a somewhat cheap valuation: IDXX is cheaper than 72.58% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 54.75 | ||
| EV/EBITDA | 37.24 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The excellent profitability rating of IDXX may justify a higher PE ratio.
- A more expensive valuation may be justified as IDXX's earnings are expected to grow with 14.13% in the coming years.
PEG (NY)3.03
PEG (5Y)2.81
EPS Next 2Y14.65%
EPS Next 3Y14.13%
5. Dividend
5.1 Amount
- IDXX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
IDEXX LABORATORIES INC / IDXX FAQ
What is the ChartMill fundamental rating of IDEXX LABORATORIES INC (IDXX) stock?
ChartMill assigns a fundamental rating of 7 / 10 to IDXX.
What is the valuation status of IDEXX LABORATORIES INC (IDXX) stock?
ChartMill assigns a valuation rating of 4 / 10 to IDEXX LABORATORIES INC (IDXX). This can be considered as Fairly Valued.
Can you provide the profitability details for IDEXX LABORATORIES INC?
IDEXX LABORATORIES INC (IDXX) has a profitability rating of 9 / 10.
What are the PE and PB ratios of IDEXX LABORATORIES INC (IDXX) stock?
The Price/Earnings (PE) ratio for IDEXX LABORATORIES INC (IDXX) is 51.13 and the Price/Book (PB) ratio is 32.97.
What is the expected EPS growth for IDEXX LABORATORIES INC (IDXX) stock?
The Earnings per Share (EPS) of IDEXX LABORATORIES INC (IDXX) is expected to grow by 16.89% in the next year.